Thienson Vu

Thienson Vu

Imperial College London - London / United Kingdom
Others
AD Scientific Index ID: 5521033
person_outline Thienson Vu's MOST POPULAR ARTICLES
1-) Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trialTP Nguyen, Q Do, LT Phan, DV Dinh, H Khong, LV Hoang, TV Nguyen, ...The Lancet Regional Health–Western Pacific 24, 2022152022
2-) COLD-PCR method for early detection of antiviral drug-resistance mutations in treatment-naive children with chronic hepatitis BTTB Phung, SV Chu, ST Vu, HT Pham, HM Nguyen, HD Nguyen, NT Le, ...Diagnostics 10 (7), 491, 202092020
3-) The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled phase 3 trialTP Nguyen, Q Do, LT Phan, DD Anh, H Khong, TV Nguyen, LV Hoang, ...medRxiv, 2022.03. 22.22272739, 202262022
4-) Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccineTP Nguyen, Q Do, LT Phan, DV Dinh, H Khong, LV Hoang, TV Nguyen, ...medRxiv, 2021.07. 22.21260942, 202162021
5-) Fast and Sensitive Real-Time PCR Detection of Major Antiviral-Drug Resistance Mutations in Chronic Hepatitis B Patients by Use of a Predesigned Panel of Locked-Nucleic-Acid …SV Chu, ST Vu, HM Nguyen, NT Le, PT Truong, VTT Vu, TTB Phung, ...Journal of Clinical Microbiology 59 (10), 10.1128/jcm. 00936-21, 202142021